PT-141 (Bremelanotide) is a synthetic peptide belonging to the melanocortin family, originally developed as an analogue of α-MSH (alpha-melanocyte-stimulating hormone). Unlike compounds that act primarily on vascular pathways, PT-141 has been engineered to target melanocortin receptors within the central nervous system, particularly MC3R and MC4R, making it distinct from other peptides studied in similar fields.
Researchers have shown interest in PT-141 for its potential roles in:
-
Sexual function studies – investigating the modulation of arousal through melanocortin receptor activity.
-
Neuroendocrine research – assessing the influence of PT-141 on hypothalamic and pituitary signalling pathways.
-
Central nervous system function – exploring its mechanisms of action on brain receptor pathways.
-
Novel peptide mechanisms – studying its distinction from nitric oxide-mediated vasodilation, offering a unique research perspective.
This peptide has become a valuable subject of study for laboratories interested in melanocortin signalling, neuroendocrine pathways, and central receptor-mediated processes, providing researchers with a novel model for evaluating alternative peptide mechanisms in scientific studies.
Reconstitution Instructions:
Reconstitute with BAC water. Refrigerate after reconstitution and use under sterile research conditions. Use our Peptide Calculator
For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.